Skip to main content

Charles River Laboratories International, Inc.

CRL
Exchange
NYSE
Industry
Services-Commercial Physical & Biological Research
SEC CIK
0001100682

In the last 90 days, Charles River Laboratories International, Inc. insiders filed 1 open-market purchase and 8 sales; 571 institutions reported holding it in 13F filings for Q2 2026, worth $12.9B in total; Harris Associates (Oakmark) is the only superinvestor holding it.

Key figures

Market capClose on Nov 10, 2026
$16.6B
Insider buysLast 90 days, $2.97K in total
1
Insider sellsLast 90 days, $23.1M in total
8
13F holdersQ2 2026, +15 vs. previous quarter
571
13F valueReported value at the end of Q2 2026
$12.9B
Superinvestors holdingAt the end of Q2 2026
1

Price chart

From SEC filings, in USD.

Revenue, FY2025
$4.02B
−0.9% year over year
Net income, FY2025
-$144.3M
−750.1% year over year
Free cash flow, FY2025
$518.5M
+3.4% year over year
Revenue, Q3 FY2026
$982.7M
−2.2% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2025: $144.3M (3.6% of revenue).

Short interest

See short data

From FINRA, settlement date Oct 15, 2026.

Short interest
2.83M
Shares sold short
Change
−44.5K
−1.6% vs. previous
Days to cover
2.90
At average daily volume

Superinvestors holding CRL, Q2 2026

Go to the superinvestors tab

1 superinvestor reports holding Charles River Laboratories International, Inc. on Form 13F. Percentages are the stock's share of each portfolio.

Harris Associates (Oakmark)

Bill Nygren

0.7%

Charles River Laboratories International, Inc.'s share of the portfolio

Shares
2,241,144
Value
$508.3M

Latest insider trades

See all insider trades

Open-market purchases and sales by Charles River Laboratories International, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 26, 2026 (view filing)4:51 PM ETOct 224 daysFoster James CDirectorSSale−24.0K$350.00−$8.41M−43.2%31.6K after10b5-1
Oct 23, 2026 (view filing)6:45 PM ETOct 212 daysParisotto Shannon MCEVP, Disc & Safety AssessmentSSale−2.16K$344.41−$742.5K−31.0%4.81K after10b5-1
Oct 7, 2026 (view filing)8:32 PM ETOct 52 daysParisotto Shannon MCEVP, Disc & Safety AssessmentSSale−981$308.44−$302.6K−16.9%4.81K after10b5-1
Oct 2, 2026 (view filing)4:27 PM ETSep 302 daysColeman GlennEVP & Chief Financial OfficerPPurchase+10$297.43+$2.97K0.0%27.8K after
Aug 27, 2026 (view filing)4:21 PM ETAug 252 daysFoster James CDirectorSSale−33.6K$300.00−$10.1M−51.5%31.6K after10b5-1
Aug 20, 2026 (view filing)4:33 PM ETAug 191 dayParisotto Shannon MCEVP, Disc & Safety AssessmentSSale−2.04K$294.12−$599.7K−29.8%4.81K after10b5-1
Aug 20, 2026 (view filing)4:31 PM ETAug 182 daysAndrews Nancy CDirectorSSale−573$285.24−$163.4K−28.5%1.44K after
Aug 13, 2026 (view filing)4:37 PM ETAug 112 daysGirshick BirgitChief Executive OfficerSSale−6.50K$279.90−$1.82M−15.3%36.0K after10b5-1
Aug 13, 2026 (view filing)4:34 PM ETAug 112 daysParisotto Shannon MCEVP, Disc & Safety AssessmentSSale−3.71K$279.66−$1.04M−43.6%4.81K after10b5-1
Aug 11, 2026 (view filing)4:35 PM ETAug 101 dayFoster James CDirectorSSale−28.7K$275.00−$7.90M−47.6%31.6K after10b5-1

Top 10 13F holders, Q2 2026

See all 571 holders

The largest institutional positions in Charles River Laboratories International, Inc. at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding CRL in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
FMR LLC4,239,752$961.5M0.04%+783,508+22.7%Added
BlackRock, Inc.3,798,560$861.5M0.01%−60,540−1.6%Reduced
Vanguard Capital Management LLC3,149,288$714.2M0.02%−52,916−1.7%Reduced
Invesco Ltd.2,984,785$676.9M0.05%+587,533+24.5%Added
Harris Associates L PSuperinvestorHarris Associates (Oakmark)2,241,144$508.3M0.68%+87,848+4.1%Added
Vanguard Portfolio Management LLC2,210,979$501.4M0.02%−83,691−3.6%Reduced
Allspring Global Investments Holdings, LLC1,905,247$436.5M0.67%−88,069−4.4%Reduced
State Street Corp1,864,284$422.8M0.01%−9,334−0.5%Reduced
Dimensional Fund Advisors LP1,648,450$373.8M0.07%−4,034−0.2%Reduced
Ariel Investments, LLC1,506,185$341.6M3.41%+62,002+4.3%Added

Holders of 5% or more of CRL

See all 4 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Charles River Laboratories International, Inc..

Largest holders of CRL from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
FMR LLC13G/A12.40%5.92M shares+2.20 ppfrom 10.20%Feb 9, 20226 filingsNov 5, 2026SEC
Vanguard Capital Management LLC13G7.38%3.63M sharesNewApr 29, 20261 filingApr 29, 2026SEC
BlackRock, Inc.13G/A6.90%3.52M shares–Oct 22, 20243 filingsApr 17, 2025SEC
Invesco Ltd.13G6.20%2.98M shares+1.30 ppfrom 4.90%Feb 12, 20263 filingsAug 13, 2026SEC

6 members of Congress reported 10 trades in Charles River Laboratories International, Inc. since 2020. Newest filings:

  1. Jefferson Shreve

    House · IN · Jun 22, 2025

    Sell$15K-$50K

  2. Jefferson Shreve

    House · IN · Jun 22, 2025

    Buy$15K-$50K

  3. Robert P. Bresnahan, Jr.

    House · PA · May 31, 2025

    Sell$1K-$15K

  4. Robert P. Bresnahan, Jr.

    House · PA · May 8, 2025

    Buy$15K-$50K

  5. Julie Johnson

    House · TX · Feb 12, 2025

    Buy$1K-$15K